科迈迪克斯 CRMD
$5.32 +$0.09 (+1.72%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $5.35 +0.56%
开盘$5.25
昨收$5.23
当日区间$5.10 – $5.34
成交量1.62M
市值$414.66M
市盈率（TTM）2.4
股息率–
CRMD 相关新闻
匹配 CorMedix 或代码 CRMD 的头条新闻，按最新排序。
- Analysts Are Bullish on Top Healthcare Stocks: Parabilis Medicines, Inc. (PBLS), Cormedix (CRMD) 正面
- Needham Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $15
- H.C. Wainwright Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $13
- RBC Capital Maintains CorMedix(CRMD.US) With Buy Rating, Raises Target Price to $14 正面
- RBC Capital Maintains CorMedix(CRMD.US) With Buy Rating, Cuts Target Price to $13 负面
- Truist Financial Maintains CorMedix(CRMD.US) With Buy Rating
- A Quick Look at Today's Ratings for CorMedix(CRMD.US), With a Forecast Between $13 to $15
- RBC Capital Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $13
- Needham Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $14
- Leerink Partners Maintains CorMedix(CRMD.US) With Buy Rating, Announces Target Price $13
- Needham Maintains CorMedix(CRMD.US) With Buy Rating, Cuts Target Price to $14 负面
- Analysts' Top Healthcare Picks: Cormedix (CRMD), CG Oncology, Inc. (CGON)
- RBC Capital Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $14
- Leerink Partners Maintains CorMedix(CRMD.US) With Buy Rating, Raises Target Price to $16 正面
- Truist Financial Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $16
暂无评论——快来第一个聊聊 CRMD。
登录后参与讨论。